Zobrazeno 1 - 10
of 257
pro vyhledávání: '"Camille N, Abboud"'
Autor:
Francesca Ferraro, Agata Gruszczynska, Marianna B. Ruzinova, Christopher A. Miller, Mary Elizabeth Percival, Geoffrey L. Uy, Iskra Pusic, Meagan A. Jacoby, Mathew J. Christopher, Miriam Y. Kim, Peter Westervelt, Amanda F. Cashen, Mark A. Schroeder, John F. DiPersio, Camille N. Abboud, Lukas D. Wartman, Feng Gao, Daniel C. Link, Timothy J. Ley, John S. Welch
Publikováno v:
Haematologica, Vol 107, Iss 7 (2022)
Externí odkaz:
https://doaj.org/article/a2116fd8e43648e69c98851780c8a622
Autor:
Ramzi Abboud, Ezhilarasi Chendamarai, Michael P. Rettig, Kathryn M. Trinkaus, Peter A. Riedell, Camille N. Abboud, Armin Ghobadi, Iskra Pusic, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy
Publikováno v:
Haematologica, Vol 105, Iss 8 (2020)
Externí odkaz:
https://doaj.org/article/b872c006c4dc48ef8679958f41c2061e
Autor:
Ramzi Abboud, Jaebok Choi, Peter Ruminski, Mark A. Schroeder, Sena Kim, Camille N. Abboud, John F. DiPersio
Publikováno v:
Therapeutic Advances in Hematology, Vol 11 (2020)
Allogeneic hematopoietic transplantation (allo-HCT) is a curative therapy for a variety of hematologic malignancies, primarily through immune-mediated clearance of malignant cells. This graft- versus -leukemia (GvL) effect is mediated by alloreactive
Externí odkaz:
https://doaj.org/article/9bc5ebb092fb4e7db9d766282057dbec
Autor:
Ramzi Abboud, Se Young Han, Eric J. Duncavage, Amanda F. Cashen, Cara Lunn Shirai, John S. Welch, John F. DiPersio, Camille N. Abboud
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
Externí odkaz:
https://doaj.org/article/f97856b44e5c47ad8037717714a666a9
Autor:
Todd A. Fehniger, John DiPersio, Mark A. Schroeder, Keith E. Stockerl-Goldstein, Iskra Pusic, Meagan A. Jacoby, Peter Westervelt, Geoffrey L. Uy, Camille N. Abboud, Rizwan Romee, Feng Gao, Sridhar Nonavinkere Srivatsan, Natalia Jaeger, Matthew L. Cooper, Jennifer A. Foltz, Michelle Becker-Hapak, Ethan McClain, Sweta Desai, Timothy Schappe, Mark Foster, Julia A. Wagner, Pamela Wong, Carly C. Neal, Celia C. Cubitt, Amanda F. Cashen, Melissa M. Berrien-Elliott
Supplemental figures S1-S11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe929f05058f62cb2a4f7f62cae4b4a
https://doi.org/10.1158/2159-8290.22534990.v1
https://doi.org/10.1158/2159-8290.22534990.v1
Autor:
Todd A. Fehniger, John DiPersio, Mark A. Schroeder, Keith E. Stockerl-Goldstein, Iskra Pusic, Meagan A. Jacoby, Peter Westervelt, Geoffrey L. Uy, Camille N. Abboud, Rizwan Romee, Feng Gao, Sridhar Nonavinkere Srivatsan, Natalia Jaeger, Matthew L. Cooper, Jennifer A. Foltz, Michelle Becker-Hapak, Ethan McClain, Sweta Desai, Timothy Schappe, Mark Foster, Julia A. Wagner, Pamela Wong, Carly C. Neal, Celia C. Cubitt, Amanda F. Cashen, Melissa M. Berrien-Elliott
Supplementary patient data, supplementary materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088ed51bf0b4d99f3c4bac49d302f9c5
https://doi.org/10.1158/2159-8290.22534987.v1
https://doi.org/10.1158/2159-8290.22534987.v1
Autor:
Todd A. Fehniger, John DiPersio, Mark A. Schroeder, Keith E. Stockerl-Goldstein, Iskra Pusic, Meagan A. Jacoby, Peter Westervelt, Geoffrey L. Uy, Camille N. Abboud, Rizwan Romee, Feng Gao, Sridhar Nonavinkere Srivatsan, Natalia Jaeger, Matthew L. Cooper, Jennifer A. Foltz, Michelle Becker-Hapak, Ethan McClain, Sweta Desai, Timothy Schappe, Mark Foster, Julia A. Wagner, Pamela Wong, Carly C. Neal, Celia C. Cubitt, Amanda F. Cashen, Melissa M. Berrien-Elliott
Supplemental patient tables (1-3) and mass cytometry reagent table (4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227e2e0d0256eae251fafb6cfd1f864e
https://doi.org/10.1158/2159-8290.22534984
https://doi.org/10.1158/2159-8290.22534984
Autor:
Ethan McClain, Sweta Desai, Amanda F. Cashen, Mark P. Foster, Peter Westervelt, Patrick Soon-Shiong, Michelle Becker-Hapak, Keith Stockerl-Goldstein, Jeffrey S. Miller, Miriam T. Jacobs, Mark A. Schroeder, Pamela Wong, Camille N. Abboud, Patrick Pence, Geoffrey L. Uy, Feng Gao, Claudio G. Brunstein, Melissa M. Berrien-Elliott, Meagan A. Jacoby, Iskra Pusic, Sarah Cooley, John F. DiPersio, Todd A. Fehniger
Publikováno v:
Blood. 139:1177-1183
Natural killer (NK) cells are a promising alternative to T cells for cancer immunotherapy. Adoptive therapies with allogeneic, cytokine-activated NK cells are being investigated in clinical trials. However, the optimal cytokine support after adoptive
Autor:
Suman Kambhampati, Iskra Pusic, James M. Foran, John G. Edwards, John Lister, Farhad Ravandi, John M. Pagel, Charalambos Andreadis, Camille N. Abboud, Swapna Panuganti, Lois Kellerman, Martin S. Tallman, Richard David Mamelok, Delong Liu, Lawrence E. Morris, Saar Gill, Alicia Wong, Jack W. Hsu, Gary J. Schiller, Pinkal Desai, Hagop M. Kantarjian, Melham M. Solh, Irum Khan, Olga Frankfurt, Rodney Van Syoc, Patrick J. Stiff, Ramkumar Mandalam, Janice M. Brown, Wendy Stock, Luke P. Akard, Celalettin Ustun, Matthew J Wieduwilt
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 29
PURPOSE Standard cytotoxic induction chemotherapy for acute myeloid leukemia (AML) results in prolonged neutropenia and risk of infection. Romyelocel-L is a universal, allogeneic myeloid progenitor cell product being studied to reduce infection durin
Autor:
Amanda F. Cashen, Matthew L. Cooper, Carly Neal, Camille N. Abboud, Feng Gao, Sweta Desai, Melissa M. Berrien-Elliott, Michelle Becker-Hapak, Celia C. Cubitt, Timothy Schappe, Pamela Wong, Mark A. Schroeder, John F. DiPersio, Peter Westervelt, Julia A. Wagner, Jennifer A. Foltz, Meagan A. Jacoby, Natalia Jaeger, Iskra Pusic, Mark P. Foster, Geoffrey L. Uy, Todd A. Fehniger, Ethan McClain, Rizwan Romee, Keith Stockerl-Goldstein, Sridhar Nonavinkere Srivatsan
Publikováno v:
Cancer Discov
Natural killer (NK) cells are an emerging cancer cellular therapy and potent mediators of antitumor immunity. Cytokine-induced memory-like (ML) NK cellular therapy is safe and induces remissions in patients with acute myeloid leukemia (AML). However,